Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2020-10-12–present
James P. Kelly
Equibles does not estimate personal net worth.
Get an email with a short summary when Supernus Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get SUPN alertsAbout James P. Kelly
James P. Kelly is recorded as CFO at Supernus Pharmaceuticals, Inc. (SUPN) since October 12, 2020. Earlier roles on record: CFO at Vanda Pharmaceuticals Inc. (VNDA) until March 15, 2020. The proxy statement of Vanda Pharmaceuticals Inc. reports total compensation of $140,274 for James P. Kelly in fiscal 2020, including a base salary of $124,057. Disclosed compensation is on record for 4 fiscal years. Supernus Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Supernus Pharmaceuticals, Inc. includes Jack A. Khattar (CEO and Board Member), Jack Khattar (CEO and Board Member), Tony Kingsley (Chairman) and 7 others.
Affiliation history
-
Current
2020-10-12–present
-
Start not stated–2020-03-15
-
Start not stated–2021-08-13
Company network
Leadership on record at Supernus Pharmaceuticals, Inc.
- Jack A. Khattar CEO, Board Member
- Jack Khattar CEO, Board Member
- Tony Kingsley Chairman
- James Kelly CFO
- Timonthy C. Dec CFO
- Timothy C. Dec CFO
- Bethany L. Sensenig Board Member
- Carrolee Barlow Board Member
- Charles W. Newhall Board Member
- Frederick M. Hudson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $124,057 | $140,274 |
| 2020 | Supernus Pharmaceuticals, Inc. (SUPN) | Executive Vice President, Chief Financial Officer | $102,910 | $1,801,636 |
| 2019 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $493,370 | $2,248,410 |
| 2018 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $479,000 | $2,401,385 |
| 2017 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $465,000 | $2,276,307 |
Recent activity
No call appearances or filed executive changes recorded yet.